Evaluation of serum eosinophil cationic protein as a predictive marker for asthma exacerbation in patients with persistent disease

Background Eosinophilic inflammation is a feature of asthma. However, serological markers to indicate eosinophil activation in this process are not fully defined.

[1]  N. Frossard,et al.  Repeated Inhalation of Low Doses of Cat Allergen That Do Not Induce Clinical Symptoms Increases Bronchial Hyperresponsiveness and Eosinophil Cationic Protein Levels , 1999, International Archives of Allergy and Immunology.

[2]  P. O'Byrne,et al.  Induced sputum, bronchoalveolar lavage and blood from mild asthmatics: inflammatory cells, lymphocyte subsets and soluble markers compared. , 1998, European Respiratory Journal.

[3]  Iguchi,et al.  Clinical utility of serum levels of eosinophil cationic protein (ECP) for monitoring and predicting clinical course in childhood asthma , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[4]  K. Kubo,et al.  Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma. , 1997, Chest.

[5]  F. Hargreave,et al.  Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. , 1997, American journal of respiratory and critical care medicine.

[6]  B. Peper,et al.  Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  N. Gökçora,et al.  Effects of inhaled steroid treatment on serum eosinophilic cationic protein (ECP) and low affinity receptor for IgE (Fc epsilon RII/sCD23) in childhood bronchial asthma. , 1996, Archives of disease in childhood.

[8]  A. Ponticiello,et al.  Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthmi , 1996, Allergy.

[9]  O. Zetterström,et al.  Eosinophil activity markers in peripheral blood have high predictive value for bronchial hyper‐reactivity in patients with , 1996 .

[10]  R. de Bruijn,et al.  Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma. , 1996, Thorax.

[11]  A. B. Kay,et al.  Eosinophil cationic protein(ECP) and eosinophil protein X (EXP) concentrations in serum and bronchial lavage fluid in asthma. effect of prednisolone treatment. , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  D. Koller,et al.  Clinical value of monitoring eosinophil activity in asthma. , 1995, Archives of disease in childhood.

[13]  S. Ahlstedt.  Clinical application of eosinophilic cationic protein in asthma. , 1995, Allergy proceedings : the official journal of regional and state allergy societies.

[14]  R. Vaughan,et al.  Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma. , 1995, The Journal of allergy and clinical immunology.

[15]  J. Hermans,et al.  Serum eosinophil cationic protein (ECP) in chronic asthma. Relationship to spirometry, flow-volume curves, PC20, and exacerbations. , 1994, Respiratory medicine.

[16]  H. Boushey,et al.  Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation. , 1994, The Journal of allergy and clinical immunology.

[17]  P. Venge.  Serum measurements of eosinophil cationic protein (ECP) in bronchial asthma , 1993, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  J. Bousquet,et al.  Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. , 1991, The Journal of allergy and clinical immunology.

[19]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[20]  P. Venge,et al.  Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. , 1990, The American review of respiratory disease.

[21]  R. Dahl,et al.  Variations of Blood Eosinophils and Eosinophil Cationic Protein in Serum in Patients with Bronchial Asthma , 1978, Allergy.